Vistagen Therapeutics (VTGN) Revenue (2011 - 2026)
Vistagen Therapeutics' Revenue was $1.48 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 504.9% from $244,000 a year earlier and up 217.4% from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Revenue (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vistagen Therapeutics' Revenue was $2.5 million through Jun 30, 2026, up 287.3% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $1.27 million, up 161.1% from FY2025.
- Revenue shows a five-year compound annual growth rate of 3.1% (FY2021 to FY2026).
- In earlier fiscal years, Revenue was $486,000 in FY2025 (-54.3%), $1.06 million in FY2024 (+368.7%), $227,000 in FY2023 (-79.5%) and $1.11 million in FY2022 (+1.8%).
- The fiscal Q1 2027 figure marks the highest quarterly Revenue in data going back to fiscal Q1 2012.
- Compared with a year earlier, Revenue was higher in four of the last six quarters, with growth averaging 114.0%.
- The best year-over-year quarter for Revenue over five years was fiscal Q1 2027 (growth of 504.9%); the worst was fiscal Q4 2022 (a decline of 91.2%).
- Per Business Quant data, VTGN's Revenue in the three fiscal quarters before Q1 2027 was $465,000 (Q4 2026), $303,000 (Q3 2026) and $258,000 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Vistagen Therapeutics | 8.49 Mn | -207.59 Mn | - | 1.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.48 Mn |
| Mar 31, 2026 | 465,000.00 |
| Dec 31, 2025 | 303,000.00 |
| Sep 30, 2025 | 258,000.00 |
| Jun 30, 2025 | 244,000.00 |
| Mar 31, 2025 | -15,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 183,000.00 |
| Jun 30, 2024 | 84,000.00 |
| Mar 31, 2024 | 164,000.00 |
| Dec 31, 2023 | 411,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 176,000.00 |
| Dec 31, 2022 | 180,000.00 |
| Sep 30, 2022 | 893,000.00 |
| Jun 30, 2022 | 310,100.00 |
| Mar 31, 2022 | 39,000.00 |
| Dec 31, 2021 | 358,000.00 |
| Sep 30, 2021 | 358,000.00 |
API Access
Vistagen Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();